Eraso A - Search Results

1

Validation of a prognostic model for predicting larynx preservation outcome (TALK score) in a Southern European population.

Marruecos-Querol J, Rubió-Casadevall J, Lozano A, Buxó M, Puigdemont M, Linares I, Planas I, Vayreda J, Cirauqui B, Taberna M, Quiroga V, Tobed M, Borés A, Recalde S, Saigi M, Felip E, Eraso A, Mesía R. Marruecos-Querol J, et al. Among authors: eraso a. Clin Transl Oncol. 2023 Aug;25(8):2384-2392. doi: 10.1007/s12094-023-03121-9. Epub 2023 Mar 21. Clin Transl Oncol. 2023. PMID: 36943650

2

Preoperative induction chemotherapy followed by concurrent chemoradiotherapy in advanced carcinoma of the oral cavity and oropharynx.

Giralt JL, Gonzalez J, del Campo JM, Maldonado J, Sanz X, Pamias J, Eraso A, Bescos S, Raspall G. Giralt JL, et al. Among authors: eraso a. Cancer. 2000 Sep 1;89(5):939-45. doi: 10.1002/1097-0142(20000901)89:5<939::aid-cncr1>3.0.co;2-6. Cancer. 2000. PMID: 10964322 Clinical Trial.

3

The expression of epidermal growth factor receptor results in a worse prognosis for patients with rectal cancer treated with preoperative radiotherapy: a multicenter, retrospective analysis.

Giralt J, de las Heras M, Cerezo L, Eraso A, Hermosilla E, Velez D, Lujan J, Espin E, Rosello J, Majó J, Benavente S, Armengol M, de Torres I; Grupo Español de Investigacion Clinica en Oncologia Radioterápica (GICOR). Giralt J, et al. Among authors: eraso a. Radiother Oncol. 2005 Feb;74(2):101-8. doi: 10.1016/j.radonc.2004.12.021. Radiother Oncol. 2005. PMID: 15816107 Clinical Trial.

4

Epidermal growth factor receptor is a predictor of tumor response in locally advanced rectal cancer patients treated with preoperative radiotherapy.

Giralt J, Eraso A, Armengol M, Rosselló J, Majó J, Ares C, Espin E, Benavente S, de Torres I. Giralt J, et al. Among authors: eraso a. Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1460-5. doi: 10.1016/s0360-3016(02)03752-5. Int J Radiat Oncol Biol Phys. 2002. PMID: 12459370

5

Tumor Bed Boost Radiotherapy in the Conservative Treatment of Breast Cancer: A Review of Intra-Operative Techniques and Outcomes.

Sanz J, Eraso A, Ibáñez R, Williams R, Algara M. Sanz J, et al. Among authors: eraso a. Cancers (Basel). 2023 Aug 8;15(16):4025. doi: 10.3390/cancers15164025. Cancers (Basel). 2023. PMID: 37627053 Free PMC article. Review.

6

Time trends and survival of marginal zone lymphoma over 25 years in Girona, Spain (1994-2018).

Auñón C, Sanvisens A, Turon E, Vidal-Vila A, Puigdemont M, Osca-Gelis G, Eraso A, Marcos-Gragera R. Auñón C, et al. Among authors: eraso a. Cancer Med. 2023 Jun;12(11):12343-12353. doi: 10.1002/cam4.5935. Epub 2023 Apr 19. Cancer Med. 2023. PMID: 37076996 Free PMC article.

7

Enhancer-promoter interactions can bypass CTCF-mediated boundaries and contribute to phenotypic robustness.

Chakraborty S, Kopitchinski N, Zuo Z, Eraso A, Awasthi P, Chari R, Mitra A, Tobias IC, Moorthy SD, Dale RK, Mitchell JA, Petros TJ, Rocha PP. Chakraborty S, et al. Among authors: eraso a. Nat Genet. 2023 Feb;55(2):280-290. doi: 10.1038/s41588-022-01295-6. Epub 2023 Jan 30. Nat Genet. 2023. PMID: 36717694 Free PMC article.

8

Subclinical Left Ventricular Dysfunction Detected by Speckle-Tracking Echocardiography in Breast Cancer Patients Treated With Radiation Therapy: A Six-Month Follow-Up Analysis (MEDIRAD EARLY-HEART study).

Locquet M, Spoor D, Crijns A, van der Harst P, Eraso A, Guedea F, Fiuza M, Santos SCR, Combs S, Borm K, Mousseaux E, Gencer U, Frija G, Cardis E, Langendijk H, Jacob S. Locquet M, et al. Among authors: eraso a. Front Oncol. 2022 Jun 28;12:883679. doi: 10.3389/fonc.2022.883679. eCollection 2022. Front Oncol. 2022. PMID: 35837099 Free PMC article.

9

Effectiveness and safety of intraoperative radiotherapy (IORT) with low-energy X-rays (INTRABEAM^®) for accelerated partial breast irradiation (APBI).

Laplana M, García-Marqueta M, Sánchez-Fernández JJ, Martínez-Pérez E, Pérez-Montero H, Martínez-Montesinos I, Eraso A, Saldaña P, Martín R, Martín MI, Pla MJ, García-Tejedor A, Guedea F. Laplana M, et al. Among authors: eraso a. Clin Transl Oncol. 2022 Sep;24(9):1732-1743. doi: 10.1007/s12094-022-02823-w. Epub 2022 Mar 19. Clin Transl Oncol. 2022. PMID: 35305245

10

Evidence-based guidelines for hypofractionated radiation in breast cancer: conclusions of the Catalan expert working group.

Eraso A, Sanz J, Mollà M, Reyes V, Pedro A, Arenas M, Martinez E, Ballester R, Cambra MJ, García V, Prades JL, Borras JM, Algara M. Eraso A, et al. Clin Transl Oncol. 2022 Aug;24(8):1580-1587. doi: 10.1007/s12094-022-02798-8. Epub 2022 Feb 21. Clin Transl Oncol. 2022. PMID: 35190961 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

57 results

Search Page